or Try an Advanced Search...

    Technical Analysis for BNR - Burning Rock Biotech Limited

    Grade Last Price % Change Price Change
    C 4.64 0.87% 0.04
    BNR closed up 0.87 percent on Wednesday, November 20, 2024, on 9 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical BNR trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Up 5 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Narrow Range Bar Range Contraction 0.87%
    Older End-of-Day Signals for BNR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    Outside Day about 21 hours ago
    Up 3% about 21 hours ago
    Up 2% about 21 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BNR Chart by TradingView
    Basic chart:

    Profile

    Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers

    Is BNR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 Burning Rock Biotech Leads The Charge With 2 Other US Penny Stocks
    Oct 11 NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
    Sep 27 Burning Rock CFO resigns
    Sep 27 Burning Rock Announces Changes to Management and Board of Directors
    Aug 23 Burning Rock Biotech GAAP EPS of -$0.14, revenue of $18.7M
    Aug 23 Burning Rock Reports Second Quarter 2024 Financial Results
    Aug 19 Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
    Jul 11 Companies Like Burning Rock Biotech (NASDAQ:BNR) Are In A Position To Invest In Growth
    Jun 3 Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
    May 30 Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
    See more BNR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.987
    52 Week Low 2.62
    Average Volume 39,028
    200-Day Moving Average 6.22
    50-Day Moving Average 3.32
    20-Day Moving Average 3.40
    10-Day Moving Average 3.91
    Average True Range 0.38
    RSI (14) 73.75
    ADX 35.22
    +DI 36.53
    -DI 7.10
    Chandelier Exit (Long, 3 ATRs) 3.65
    Chandelier Exit (Short, 3 ATRs) 3.78
    Upper Bollinger Bands 4.64
    Lower Bollinger Band 2.15
    Percent B (%b) 1.0
    BandWidth 73.40
    MACD Line 0.29
    MACD Signal Line 0.10
    MACD Histogram 0.1922
    Fundamentals Value
    Market Cap 476.41 Million
    Num Shares 103 Million
    EPS -0.97
    Price-to-Earnings (P/E) Ratio -4.78
    Price-to-Sales 0.15
    Price-to-Book 0.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.00
    Resistance 3 (R3) 5.00 4.89 4.94
    Resistance 2 (R2) 4.89 4.80 4.89 4.92
    Resistance 1 (R1) 4.77 4.75 4.83 4.76 4.90
    Pivot Point 4.66 4.66 4.69 4.65 4.66
    Support 1 (S1) 4.53 4.57 4.59 4.52 4.38
    Support 2 (S2) 4.42 4.51 4.41 4.36
    Support 3 (S3) 4.29 4.42 4.34
    Support 4 (S4) 4.28